HIV treatment has come a long way since the early days of the epidemic. Patients can now take various combinations of dozens of medications keep the virus under control and halt their disease from decimating their immune systems and leading to more serious, often fatal outcomes. But harnessing HIV requires daily vigilance. Missing doses of the […]
United Neuroscience is developing a novel class of vaccines that target aberrant proteins implicated in neurodegenerative diseases. Now it has strong preclinical evidence showing that one of its vaccines could hold promise in Parkinson’s disease.